Concerns and motivations about COVID-19 vaccination
For those who were indifferent (June, 7% [102 of 1371]; July, 5% [59 of 1274]) or said they would not get the vaccine (June, 5% [74 of 1371]; July, 6% [71 of 1274]), the top reasons across the two surveys were “concern about the safety of the vaccine in its development” (36% [139 of 388]) and “poten...
Gespeichert in:
Veröffentlicht in: | The Lancet infectious diseases 2021-02, Vol.21 (2), p.161-163 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 163 |
---|---|
container_issue | 2 |
container_start_page | 161 |
container_title | The Lancet infectious diseases |
container_volume | 21 |
creator | Dodd, Rachael H Pickles, Kristen Nickel, Brooke Cvejic, Erin Ayre, Julie Batcup, Carys Bonner, Carissa Copp, Tessa Cornell, Samuel Dakin, Thomas Isautier, Jennifer McCaffery, Kirsten J |
description | For those who were indifferent (June, 7% [102 of 1371]; July, 5% [59 of 1274]) or said they would not get the vaccine (June, 5% [74 of 1371]; July, 6% [71 of 1274]), the top reasons across the two surveys were “concern about the safety of the vaccine in its development” (36% [139 of 388]) and “potential side effects” (10% [38 of 388]). Involving vaccine communication experts and the public in developing messaging and long-term vaccine strategy is crucial, and governments worldwide should begin preparing these strategies imminently.8 A prioritisation framework proposed by health economists might aid with the development of these strategies.9 With the Australian Government aiming for 95% uptake of the COVID-19 vaccine, communication formats used to inform members of the public about a vaccine should be suitable for people with low health literacy and education and appropriate for culturally and linguistically diverse groups and Indigenous populations.1 Primary-care doctors are likely to be at the forefront of education and administration of a COVID-19 vaccine.10 Since these doctors are a trusted source, it is important that they are supported in delivering recommendations about the COVID-19 vaccine while alleviating concerns, if we are to reach the vaccine uptake target in Australia. Supporting health-care professionals in their role as educators will ensure people have adequate and accessible information from a trusted source, to optimise vaccine uptake and ultimately reduce community transmission of COVID-19. |
doi_str_mv | 10.1016/S1473-3099(20)30926-9 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7832277</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309920309269</els_id><sourcerecordid>2481541218</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-7ef76726508525496b2be5ada6561a506c80cf134cace3caa46ef22d9bb831783</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwCaBKbGARsB0_kg0IhadUqQseW8txHHDVxsVOIvH3OEmpYIU3Y3vu3Ds6ABwjeIEgYpfPiPA4imGanmF4HipmUboDxuGbRIRQvtvfB8kIHHi_gBBxBMk-GMXhJITAMYgzWyntKj-VVTFd2dq0sja2e-e2qafZ_O3pNkLptJVKmarvHYK9Ui69PtrUCXi9v3vJHqPZ_OEpu5lFiiJSR1yXnHHMKEwopiRlOc41lYVklCFJIVMJVCWKiZJKx0pKwnSJcZHmeRIjnsQTcDX4rpt8pQulq9rJpVg7s5LuS1hpxN9OZT7Eu21FmMWY82BwujFw9rPRvhYL27gq7CwwSRAlCKMuhg4q5az3TpfbBARFx1r0rEUHUmAoetYiDXMnv9fbTv3ADYLrQaADpNZoJ7wyOuAujNOqFoU1_0R8A4XOjYY</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2481541218</pqid></control><display><type>article</type><title>Concerns and motivations about COVID-19 vaccination</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><source>ProQuest Central UK/Ireland</source><creator>Dodd, Rachael H ; Pickles, Kristen ; Nickel, Brooke ; Cvejic, Erin ; Ayre, Julie ; Batcup, Carys ; Bonner, Carissa ; Copp, Tessa ; Cornell, Samuel ; Dakin, Thomas ; Isautier, Jennifer ; McCaffery, Kirsten J</creator><creatorcontrib>Dodd, Rachael H ; Pickles, Kristen ; Nickel, Brooke ; Cvejic, Erin ; Ayre, Julie ; Batcup, Carys ; Bonner, Carissa ; Copp, Tessa ; Cornell, Samuel ; Dakin, Thomas ; Isautier, Jennifer ; McCaffery, Kirsten J</creatorcontrib><description>For those who were indifferent (June, 7% [102 of 1371]; July, 5% [59 of 1274]) or said they would not get the vaccine (June, 5% [74 of 1371]; July, 6% [71 of 1274]), the top reasons across the two surveys were “concern about the safety of the vaccine in its development” (36% [139 of 388]) and “potential side effects” (10% [38 of 388]). Involving vaccine communication experts and the public in developing messaging and long-term vaccine strategy is crucial, and governments worldwide should begin preparing these strategies imminently.8 A prioritisation framework proposed by health economists might aid with the development of these strategies.9 With the Australian Government aiming for 95% uptake of the COVID-19 vaccine, communication formats used to inform members of the public about a vaccine should be suitable for people with low health literacy and education and appropriate for culturally and linguistically diverse groups and Indigenous populations.1 Primary-care doctors are likely to be at the forefront of education and administration of a COVID-19 vaccine.10 Since these doctors are a trusted source, it is important that they are supported in delivering recommendations about the COVID-19 vaccine while alleviating concerns, if we are to reach the vaccine uptake target in Australia. Supporting health-care professionals in their role as educators will ensure people have adequate and accessible information from a trusted source, to optimise vaccine uptake and ultimately reduce community transmission of COVID-19.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(20)30926-9</identifier><identifier>PMID: 33338440</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Australia ; Comment ; Communication ; Coronaviruses ; COVID-19 ; COVID-19 vaccines ; Disease transmission ; Education ; Humans ; Immunization ; Infectious diseases ; Motivation ; Pandemics ; Physicians ; SARS-CoV-2 ; Side effects ; Vaccination ; Vaccines</subject><ispartof>The Lancet infectious diseases, 2021-02, Vol.21 (2), p.161-163</ispartof><rights>2021 Elsevier Ltd</rights><rights>2021. Elsevier Ltd</rights><rights>2020 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c514t-7ef76726508525496b2be5ada6561a506c80cf134cace3caa46ef22d9bb831783</citedby><cites>FETCH-LOGICAL-c514t-7ef76726508525496b2be5ada6561a506c80cf134cace3caa46ef22d9bb831783</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2481541218?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995,64385,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33338440$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dodd, Rachael H</creatorcontrib><creatorcontrib>Pickles, Kristen</creatorcontrib><creatorcontrib>Nickel, Brooke</creatorcontrib><creatorcontrib>Cvejic, Erin</creatorcontrib><creatorcontrib>Ayre, Julie</creatorcontrib><creatorcontrib>Batcup, Carys</creatorcontrib><creatorcontrib>Bonner, Carissa</creatorcontrib><creatorcontrib>Copp, Tessa</creatorcontrib><creatorcontrib>Cornell, Samuel</creatorcontrib><creatorcontrib>Dakin, Thomas</creatorcontrib><creatorcontrib>Isautier, Jennifer</creatorcontrib><creatorcontrib>McCaffery, Kirsten J</creatorcontrib><title>Concerns and motivations about COVID-19 vaccination</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>For those who were indifferent (June, 7% [102 of 1371]; July, 5% [59 of 1274]) or said they would not get the vaccine (June, 5% [74 of 1371]; July, 6% [71 of 1274]), the top reasons across the two surveys were “concern about the safety of the vaccine in its development” (36% [139 of 388]) and “potential side effects” (10% [38 of 388]). Involving vaccine communication experts and the public in developing messaging and long-term vaccine strategy is crucial, and governments worldwide should begin preparing these strategies imminently.8 A prioritisation framework proposed by health economists might aid with the development of these strategies.9 With the Australian Government aiming for 95% uptake of the COVID-19 vaccine, communication formats used to inform members of the public about a vaccine should be suitable for people with low health literacy and education and appropriate for culturally and linguistically diverse groups and Indigenous populations.1 Primary-care doctors are likely to be at the forefront of education and administration of a COVID-19 vaccine.10 Since these doctors are a trusted source, it is important that they are supported in delivering recommendations about the COVID-19 vaccine while alleviating concerns, if we are to reach the vaccine uptake target in Australia. Supporting health-care professionals in their role as educators will ensure people have adequate and accessible information from a trusted source, to optimise vaccine uptake and ultimately reduce community transmission of COVID-19.</description><subject>Australia</subject><subject>Comment</subject><subject>Communication</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Disease transmission</subject><subject>Education</subject><subject>Humans</subject><subject>Immunization</subject><subject>Infectious diseases</subject><subject>Motivation</subject><subject>Pandemics</subject><subject>Physicians</subject><subject>SARS-CoV-2</subject><subject>Side effects</subject><subject>Vaccination</subject><subject>Vaccines</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkMtOwzAQRS0EoqXwCaBKbGARsB0_kg0IhadUqQseW8txHHDVxsVOIvH3OEmpYIU3Y3vu3Ds6ABwjeIEgYpfPiPA4imGanmF4HipmUboDxuGbRIRQvtvfB8kIHHi_gBBxBMk-GMXhJITAMYgzWyntKj-VVTFd2dq0sja2e-e2qafZ_O3pNkLptJVKmarvHYK9Ui69PtrUCXi9v3vJHqPZ_OEpu5lFiiJSR1yXnHHMKEwopiRlOc41lYVklCFJIVMJVCWKiZJKx0pKwnSJcZHmeRIjnsQTcDX4rpt8pQulq9rJpVg7s5LuS1hpxN9OZT7Eu21FmMWY82BwujFw9rPRvhYL27gq7CwwSRAlCKMuhg4q5az3TpfbBARFx1r0rEUHUmAoetYiDXMnv9fbTv3ADYLrQaADpNZoJ7wyOuAujNOqFoU1_0R8A4XOjYY</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Dodd, Rachael H</creator><creator>Pickles, Kristen</creator><creator>Nickel, Brooke</creator><creator>Cvejic, Erin</creator><creator>Ayre, Julie</creator><creator>Batcup, Carys</creator><creator>Bonner, Carissa</creator><creator>Copp, Tessa</creator><creator>Cornell, Samuel</creator><creator>Dakin, Thomas</creator><creator>Isautier, Jennifer</creator><creator>McCaffery, Kirsten J</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>5PM</scope></search><sort><creationdate>20210201</creationdate><title>Concerns and motivations about COVID-19 vaccination</title><author>Dodd, Rachael H ; Pickles, Kristen ; Nickel, Brooke ; Cvejic, Erin ; Ayre, Julie ; Batcup, Carys ; Bonner, Carissa ; Copp, Tessa ; Cornell, Samuel ; Dakin, Thomas ; Isautier, Jennifer ; McCaffery, Kirsten J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-7ef76726508525496b2be5ada6561a506c80cf134cace3caa46ef22d9bb831783</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Australia</topic><topic>Comment</topic><topic>Communication</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Disease transmission</topic><topic>Education</topic><topic>Humans</topic><topic>Immunization</topic><topic>Infectious diseases</topic><topic>Motivation</topic><topic>Pandemics</topic><topic>Physicians</topic><topic>SARS-CoV-2</topic><topic>Side effects</topic><topic>Vaccination</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dodd, Rachael H</creatorcontrib><creatorcontrib>Pickles, Kristen</creatorcontrib><creatorcontrib>Nickel, Brooke</creatorcontrib><creatorcontrib>Cvejic, Erin</creatorcontrib><creatorcontrib>Ayre, Julie</creatorcontrib><creatorcontrib>Batcup, Carys</creatorcontrib><creatorcontrib>Bonner, Carissa</creatorcontrib><creatorcontrib>Copp, Tessa</creatorcontrib><creatorcontrib>Cornell, Samuel</creatorcontrib><creatorcontrib>Dakin, Thomas</creatorcontrib><creatorcontrib>Isautier, Jennifer</creatorcontrib><creatorcontrib>McCaffery, Kirsten J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dodd, Rachael H</au><au>Pickles, Kristen</au><au>Nickel, Brooke</au><au>Cvejic, Erin</au><au>Ayre, Julie</au><au>Batcup, Carys</au><au>Bonner, Carissa</au><au>Copp, Tessa</au><au>Cornell, Samuel</au><au>Dakin, Thomas</au><au>Isautier, Jennifer</au><au>McCaffery, Kirsten J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Concerns and motivations about COVID-19 vaccination</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>21</volume><issue>2</issue><spage>161</spage><epage>163</epage><pages>161-163</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><abstract>For those who were indifferent (June, 7% [102 of 1371]; July, 5% [59 of 1274]) or said they would not get the vaccine (June, 5% [74 of 1371]; July, 6% [71 of 1274]), the top reasons across the two surveys were “concern about the safety of the vaccine in its development” (36% [139 of 388]) and “potential side effects” (10% [38 of 388]). Involving vaccine communication experts and the public in developing messaging and long-term vaccine strategy is crucial, and governments worldwide should begin preparing these strategies imminently.8 A prioritisation framework proposed by health economists might aid with the development of these strategies.9 With the Australian Government aiming for 95% uptake of the COVID-19 vaccine, communication formats used to inform members of the public about a vaccine should be suitable for people with low health literacy and education and appropriate for culturally and linguistically diverse groups and Indigenous populations.1 Primary-care doctors are likely to be at the forefront of education and administration of a COVID-19 vaccine.10 Since these doctors are a trusted source, it is important that they are supported in delivering recommendations about the COVID-19 vaccine while alleviating concerns, if we are to reach the vaccine uptake target in Australia. Supporting health-care professionals in their role as educators will ensure people have adequate and accessible information from a trusted source, to optimise vaccine uptake and ultimately reduce community transmission of COVID-19.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>33338440</pmid><doi>10.1016/S1473-3099(20)30926-9</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1473-3099 |
ispartof | The Lancet infectious diseases, 2021-02, Vol.21 (2), p.161-163 |
issn | 1473-3099 1474-4457 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7832277 |
source | MEDLINE; Access via ScienceDirect (Elsevier); ProQuest Central UK/Ireland |
subjects | Australia Comment Communication Coronaviruses COVID-19 COVID-19 vaccines Disease transmission Education Humans Immunization Infectious diseases Motivation Pandemics Physicians SARS-CoV-2 Side effects Vaccination Vaccines |
title | Concerns and motivations about COVID-19 vaccination |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T16%3A42%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Concerns%20and%20motivations%20about%20COVID-19%20vaccination&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Dodd,%20Rachael%20H&rft.date=2021-02-01&rft.volume=21&rft.issue=2&rft.spage=161&rft.epage=163&rft.pages=161-163&rft.issn=1473-3099&rft.eissn=1474-4457&rft_id=info:doi/10.1016/S1473-3099(20)30926-9&rft_dat=%3Cproquest_pubme%3E2481541218%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2481541218&rft_id=info:pmid/33338440&rft_els_id=S1473309920309269&rfr_iscdi=true |